IM Cannabis (IMCC) Share-based Compensation (2020 - 2025)
IM Cannabis' (IMCC) quarterly Share-based Compensation came in at $1453.3 in Q3 2025, down 99.19% year-on-year from $178865.0 in Q3 2024, and down 49.66% quarter-over-quarter from $2886.8 in Q2 2025.
IM Cannabis (IMCC) Share-based Compensation (2020 - 2025) Analysis & Trends
IM Cannabis' Share-based Compensation history runs 6 years deep, the most recent figure standing at $1453.3 for Q3 2025.
- On a quarterly basis, Share-based Compensation fell 99.19% year-over-year to $1453.3 in Q3 2025; TTM through Dec 2025 was $9915.5, a 96.33% decrease from a year earlier, with the FY2025 full-year figure at $10039.2, down 96.28% from the prior year.
- Share-based Compensation fell to $1453.3 in Q3 2025 per IMCC's latest filing, from $2886.8 in the prior quarter.
- Across five years, Share-based Compensation topped out at $4.7 million in Q4 2021 and bottomed at -$320941.4 in Q3 2021.
- The 5-year median for Share-based Compensation is $145456.4 (2023), against an average of $491001.7.
- Biggest YoY gain for Share-based Compensation was 385.47% in 2021; the steepest drop was 160.75% in 2021.
- Year by year, Share-based Compensation stood at $4.7 million in 2021, then plunged by 92.36% to $355827.5 in 2022, then tumbled by 118.79% to -$66842.7 in 2023, then surged by 105.35% to $3579.2 in 2024, then slumped by 59.4% to $1453.3 in 2025.
- Per Business Quant, the three latest IMCC Share-based Compensation figures stand at $1453.3 (Q3 2025), $2886.8 (Q2 2025), and $5575.3 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,453.27 |
| Sep 30, 2025 | 1,453.27 |
| Jun 30, 2025 | 2,886.85 |
| Jun 30, 2025 | 2,886.85 |
| Mar 31, 2025 | 5,575.33 |
| Mar 31, 2025 | 5,575.33 |
| Dec 31, 2024 | 3,579.25 |
| Dec 31, 2024 | 3,579.25 |
| Sep 30, 2024 | 178,865.03 |
| Sep 30, 2024 | 178,865.03 |
| Jun 30, 2024 | 64,340.37 |
| Jun 30, 2024 | 64,340.37 |
| Mar 31, 2024 | 23,747.62 |
| Mar 31, 2024 | 23,747.62 |
| Dec 31, 2023 | -66,842.73 |
| Dec 31, 2023 | -66,842.73 |
| Sep 30, 2023 | 145,456.44 |
| Sep 30, 2023 | 145,456.44 |
| Jun 30, 2023 | -101,989.99 |
| Jun 30, 2023 | -101,989.99 |